hepatitis B gene therapy (Chiron Viagene)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namehepatitis B gene therapy (Chiron Viagene)
Drug Alias NameHBV gene therapy (Chiron Viagene)HBV immunotherapeutic (Viagene)
ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesChiron Viagene Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChiron Viagene Inc
Active IndicationsN/A
Inactive IndicationsHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A